The information on this site is intended for healthcare professional in Thailand
NEW!!! Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
12th Episode on 5.00 P.M. 27th June 2025
Case Sharing : The Tumor Response and Overall Survival of Second Line Chemotherapy in Advanced Biliary Tract
Moderator
Dr.Aumkhae Sookprasert, Srinagarind Hospital
Speaker
Dr.Piangpen Jongpairat, Khonkaen Hospital
Dr.Tawasapon Thambamroong, Phramongkutklao Hostpital
Dr.Jirawat Thanestada, Maharat Nakhon Ratchasima Hospital
And Interrogator
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
11th Episode on 5.00 P.M. 20th June 2025
Updated results of the FOENIX-CCA2 trial: Efficacy and safety of Futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements
Moderator
Dr.Aumkhae Sookprasert, Srinagarind Hospital
Speaker
Dr.Krittiya Korphaisarn, Siriraj Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
10th Episode on 5.00 P.M. 13th June 2025
The Triplet Regimen Chemotherapy with effective of care for treatment of unresectable or recurrent biliary tract cancer
Moderator
Dr.Kosin Wirasorn, Srinagarind Hospital
Speaker
Dr.Suebpong Tanasanvimon, King Chulalongkorn Memorial Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
9th Episode on 5.00 P.M. 6th June 2025
The Significant Benefits of Adjuvant S-1 single agent and safety profile in Resected Biliary Tract Cancer
Moderator
Dr.Kosin Wirasorn, Srinagarind Hospital
Speaker
Dr.Patrapim Sunpaweravong, Songklanagarind Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
Special session
8th Episode on 5.00 P.M. 27th May 2025
Efficacy benefits and QoL with longer survival in later line mCRC Treatment
Moderator&Speaker
Dr.Kunlatida Maneenil, Rajavithi Hospital
Speaker
Dr.Yotsawaj Runglodvatana, Vajira Hospital
Dr.Sarat Chalongpoksinchai, Klang Hospital
And Interrogator
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
7th Episode on 5.00 P.M. 20th May 2025
Case Sharing: The safety profile of Trifluridine/Tipiracil preserves performance status and better survival outcomes in 3L of mCRC
Moderator
Dr.Naiyarat Prasongsook, Phramongkutklao Hospital
Speaker
Dr.Chayanee Samdaengpan, Chulabhorn Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
6th Episode on 5.00 P.M. 13th May 2025
The Safety and Activity of Trifluridine/Tipiracil and Ramucirumab in previously treated mCRC
Moderator
Dr. Chaiyut Charoentum, Maharaj Nakorn Chiang Mai Hospital
Speaker
Dr.Nuttapong Topibulpong, Ramathibodi Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
5th Episode on 5.00 P.M. 6th May 2025
Case Sharing : The "Cardio-Gentle" Monotherapy Regimen in Metastatic Colorectal Cancer Treatment
Moderator
Dr. Chaiyut Charoentum, Maharaj Nakorn Chiang Mai Hospital
Speaker
Dr.Duangnapa Benjawongsathien, Police Hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
4th Episode on 5.00 P.M. 25th April 2025
Case Sharing : The additional Docetaxel to S-1 in postoperative D2 resection Stage III gastric cancer with safety concerns
Moderator
Dr.Passakorn Wanchaijiraboon, Phrapokklao hospital
Speaker
Dr.Thanate Dajsakdipon, Ramathibodi hospital
Dr.Thanika Ketpueak, Maharaj Nakaorn Chiang Mai hospital
Dr.Gorawich Kerkarchachai, Vajira hospital
And Special guest
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
3rd Episode on 5.00 P.M. 18th April 2025
Case Sharing : The 8-year follow-up of postoperative D2 resection in Stage III Gastric cancer
Moderator
Dr.Passakorn Wanchaijiraboon ,Phrapokklao hospital
Speaker
Dr.Parichat Phongthai, Khon Kaen hospital
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
2nd Episode on 5.00 P.M. 11th April 2025
Case Sharing : The New Treatment Option in the fourth-line setting for GIST refractory to standard therapies with QoL
Moderator
Dr.Harit Suwanrusme ,Bumrungrad hospital
Speaker
Dr.Wendy Chan, The University of Hong Kong
Meeting record
TAIHO WEEKLY LIVE season5
BREAKING in THE CANCER TREATMENT
1st Episode on 5.00 P.M. 4th April 2025
The New Treatment Option in the fourth-line setting for GIST refractory to standard therapies with QoL.
Moderator
Dr.Harit Suwanrusme ,Bumrungrad hospital
Speaker
Dr.Thattan Suksombooncharoen, Maharaj Nakorn Chiang Mai hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
12th Episode on 5.00 P.M. 28 Jun 2024
Oral S-1 has been validate a therapeutic modality in various tumors over other 5FU. Believe it or Not!!!
Moderator
Dr.Aumkhae Sookprasert, Srinagarind hospital
Speaker
Dr.Kunlatida Maneenil Rajavithi hospital
Dr.Sutima Luangdilok King Chulalongkorn memorial hospital
Dr.Gorawich Kerkarchachai Vajira hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
11th Episode on 5.00 P.M. 21 Jun 2024
Case Sharing : The Experience of Oral DPD-inhibitory 5-FU in Higher DPD Level of Cancer
Moderator
Dr.Passakorn Wanchaijiraboon Phrapokklao hospital
Speaker
Dr.Thanate Dajsakdipon Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
10th Episode on 5.00 P.M. 14 Jun 2024
Beyond Efficacy with self-rescuing charactor of S-1 in higher DPD level of cancer
Moderator
Dr.Krittiya Korphaisarn, Siriraj hospital
Speaker
Dr.Vichien Srimuninnimit Siriraj Piyamaharajkarun
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
9th Episode on 5.00 P.M. 7 Jun 2024
The DPD level related with predicting the efficacy of chemotherapy with 5-FU
Moderator
Dr.Krittiya Korphaisarn, Siriraj hospital
Speaker
Dr.Teerada Siripoon Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
8th Episode on 5.00 P.M. 28 May 2024
Does The Crucial Importance of S-1 Compound Allows The Outstanding Therapy in Cancer Treatment?
Moderator
Dr.Kosin Wirasorn , Srinagarind hospital
Speaker
Dr.Nussara Pakvisal , King Chulalongkorn memorial hospital
Dr.Patrapim Sunpaweravong , Songklanakarind hospital
Dr.Asasiri Kankaew , Phyathai 1 hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
7th Episode on 5.00 P.M. 21 May 2024
Case sharing : The Experience of Oral DPD-inhibitory 5-FU in GI Cancer Treatment
Moderator
Dr.Kosin Wirasorn , Srinagarind hospital
Speaker
Dr.Piti Pornpraserthsook , Lopburi cancer hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
6th Episode on 5.00 P.M. 14 May 2024
Comparative Efficacy with Self-rescuing Character of S-1 Beyond Other 5-FU
Moderator
Dr.Luangyot Thongthieng , Khon Kaen hospital
Speaker
Dr.Nuttapong Topibulpong , Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
5th Episode on 5.00 P.M. 7 May 2024
The Distinctive Characteristic of Oral DPD-inhibitory 5-FU among other conventional 5-FU
Moderator
Dr.Luangyot Thongthieng , Khon Kaen hospital
Speaker
Dr.Piyarat Limpawittayakul , Chulabhon hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
4th Episode on 5.00 P.M. 3 May 2024
Debate session! What could be a considerably efficacious treatment options for mCRC patients who refractory to prior standard treatments?
Moderator
Dr.Harit Suwanrusme, M.D.,Bumrungrad hospital
Speaker
Dr.Chaiyut Charoentum, M.D. Maharaj Nakorn Chiangmai hospital.
Dr.Rattiya Cheewakriangkrai M.D., Chiangmai Ram hospital.
Dr.Passakorn Wanchaijiraboon M.D., Phrapokklao hospital.
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
3rd Episode on 5.00 P.M. 26 April 2024
Case Sharing : The experience treatment with TAS-102 combination in previously treatment mCRC.
Moderator
Dr.Harit Suwanrusme, M.D.,Bumrungrad hospital
Speaker
Dr.Saran Kitsaran, M.D. Sunpasitthipprasong hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
2nd Episode on 5.00 P.M. 19 April 2024
The evidence and consensus of previously treatment mCRC patients.
Moderator
Dr.Naiyarat Prasongsook M.D., Phramongkutklao hospital
Speaker
Dr.Ekaphop Sirachaina M.D., Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season4
ESTABLISHING CONSENSUS in Oncology Pathway to Integrative Treatment Approaches.
1st Episode on 5.00 P.M. 5 April 2024
The Magnitude of Benefit in TAS-102 combination in previously treatment mCRC patients
Moderator
Dr.Naiyarat Prasongsook M.D., Phramongkutklao hospital
Speaker
Dr.Suebpong Tanasanvimon, M.D.,Chulalongkorn hospital.
Meeting record
Managing of Later Line Treatment in Metastatic NSCLC with Single-Agent Oral Fluoropyrimidine
Moderator :
Dr.Virote Sriuranpong ,
King Chulalongkorn Memorial Hospital, Thailand Speaker :
Assoc Prof Darren Lim, Singapore,
National University of Singapore, Singapore
Dr.Naiyarat Prasongsook,
Phramongkutklao Hospital, Thailand
Dr.Kunlatida Maneenil,
Rajavithi Hospital, Thailand
Meeting record
TAIHO WEEKLY LIVE season3, 30 Jun 2023
Ep.12 Update from American Society of Clinical Oncology (ASCO) 2023.
Moderator
Dr.Aumkhae Sookprasert, M.D.
Srinagarind hospital
Speaker
Dr.Suebpong Tanasanvimon, M.D.
King Chulalongkorn Memorial hospital
Meeting record
TAIHO WEEKLY LIVE season3, 23 Jun 2023
Ep.11 Survival Outcomes with QoL in Adjuvant Pancreatic Cancer Treatment.
Moderator
Dr.Aumkhae Sookprasert, M.D.
Srinagarind hospital
Speaker
Dr.Piti Pornpraserthsook, M.D.
Lopburi cancer hospital
Meeting record
TAIHO WEEKLY LIVE season3, 16 Jun 2023
Ep.10 An Option Combination Chemotherapy in Stage III Gastric Cancer with Favorable Safety Profile and Good Compliance. Moderator
Dr.Virote Sriuranpong, M.D.
King Chulalongkorn Memorial hospital
Speaker
Dr.Nuttapong Topibulpong M.D.
Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season3, 9 Jun 2023
Ep.9 The effect of KRAS codon 12 and 13 Mutation on The Efficacy in Previously treated mCRC Patient.
Moderator
Dr.Harit Suwanrusme, M.D.
Bumrungrad hospital
Speaker
Dr.Patrapim Sunpaweravong
Songklanakarind hospital
Meeting record
TAIHO WEEKLY LIVE season3, 31 May 2023
Ep.8 The Rechallenging Treatment in heavily pretreated mCRC.
Moderator
Dr.Harit Suwanrusme, M.D.
Bumrungrad hospital
Speaker
Dr.Vichien Srimuninnimit, M.D.
Siriraj piyamaharajkarun hospital
Meeting record
TAIHO WEEKLY LIVE season3, 24 May 2023
Ep.7 SUNLIGHT Study : A Significant Efficacy and QoL of The Combination Regimen in Later-line mCRC Treatment.
Moderator
Dr.Harit Suwanrusme, M.D.
Bumrungrad hospital
Speaker
Dr.Ekaphop Sirachainan, M.D.
Ramathibodi hospital
Meeting record
TAIHO WEEKLY LIVE season3, 17 May 2023
Ep.6 Case Sharing : Combination Regimen of pretreated mCRC in Elderly patient
Moderator
Dr.Chanyoot Bandidwattanawong, M.D.
Vajira hospital
Speaker
Dr.Rattiya Cheewakriangkrai, M.D.
Chiangmai-Ram hospital
Meeting record
TAIHO WEEKLY LIVE season3, 10 May 2023
Ep.5 Case Sharing : Significant Efficacy with QoL in Pretreated Gastric Cancer.
Moderator
Dr.Chanyoot Bandidwattanawong, M.D.
Vajira hospital
Speaker
Dr.Duangnapa Benjawongsathien, M.D.
Police hospital
Meeting record
TAIHO WEEKLY LIVE season3, 5 May 2023
Ep.4 Case Sharing : Chemotherapy Combination in Pretreated Cholangiocarcinoma Treatment.
Moderator
Dr.Teerada Siripoon, M.D.
Ramathibodi hospital
Speaker
Dr.Panuch Eiamprapaporn, M.D.
Thammasat university hospital
Meeting record
TAIHO WEEKLY LIVE season3, 28 Apr 2023
Ep.3 Adjuvant Biliary Tract Treatment with Oral 5FU in Asian Populations.
Moderator
Dr.Passakorn Wanchaijiraboon, M.D.
Phrapokklao hospital
Speaker
Dr.Siraphong Puthaveephong, M.D.
Srinagarind hospital
Meeting record
TAIHO WEEKLY LIVE season3, 21 Apr 2023
Ep.2 How to Increase the Recurrence-Inhibitory Effect with Postoperative Endocrine Therapy in Breast Cancer?
Moderator
Dr.Luangyot Thongthieng, M.D.
Khon Kaen hospital
Speaker
Dr.Asasiri Kankaew, M.D.
Phyathai 1 hospital
Meeting record
TAIHO WEEKLY LIVE season3, 7 Apr 2023
Ep.1 The Comparable Efficacy and QoL in Later-line NSCLC Treatment
Moderator
Dr.Luangyot Thongthieng, M.D.
Khon Kaen hospital
Speaker
Dr.Jirawat Thanestada M.D.
Maharat Nakhon Ratchasima hospital
Meeting record
Shifting treatment landscape of advanced cholangiocarcinoma
20 March, 2023
On Fri 17th February 2023, 6.30-8.00 P.M.
Meeting record
Navigating the treatment journey in heavity pretreated mCRC patients
On Fri 17th February 2023, 6.30-8.00 P.M.
Speaker
Dr.Prof Josep Tebernero , Universitat Autònoma de Barcelona, Spain
Meeting record
NEW INDICATION WEEKS MEETING (2nd week)
On Fri 25th November 2022, 5.00-5.30 P.M.
Moderator
Dr.Harit Suwanrusme, Bamrungrad Hospital
Topic
The Comparable Fluoropyrimidine with Standard Regimen in Pretreated Advanced NSCLC
By Dr.Kunlatida Maneenil, Rajavithi Hospital
Meeting record
NEW INDICATION WEEKS MEETING (2nd week)
On Fri 18th November 2022, 5.00-5.30 P.M.
Moderator
Dr.Harit Suwanrusme, Bamrungrad Hospital
Topic
A New Choice of Chemotherapy to Improve the Quality of Life for Adjuvant Pancreatic Cancer
By Dr.Aumkhae Sookprasert, Srinagarind Hospital
Meeting record
NEW INDICATION WEEKS MEETING (1st week)
On Fri 11th November 2022, 5.00-5.30 P.M.
Topic
The New Option of First-Line Chemotherapy with Health-related Quality of Life for Metastatic Breast Cancer
Speaker
Dr.Napa Parinyanitikul, King Chulalongkorn Memorial Hospital
Meeting record
TAIHO STAND ALONE FOR FELLOWSHIPS
[HYBRID MEETING]
Speaker
Dr.Chanyoot Bandidwattanawong,
Vajira Hospital
Dr.Vichien Srimuninnimit,
Siriraj Piyamaharajkarun Hospital
Dr.Pongwut Danchaivijitr,
Siriraj Hospital
Meeting record
"TAIHO weekly Live season2"
EP.12 1st Jul, 2022
"The Efficacy inLater line Treatment of mCRC from UK Real World Data"
by Dr.Ekaphop Sirachainan
Meeting record
"TAIHO weekly Live season2"
EP.11 24th Jun, 2022
"What is the beast sequence of standard chemo-refractory mCRC patient?"
by Dr.Vichien Srimuninnimit
Meeting record
"TAIHO weekly Live season2"
EP.10 17th Jun, 2022
"The promising efficacy with acceptable toxicities of combination treatment in 3L mCRC"
by Dr.Suebpong Tanasanvimon
Meeting record
"TAIHO weekly Live season2"
EP.9 10th Jun, 2022
"Dose the Tumour Burden and Presence of Indolent Disease affected to the treatment outcomes in 3L mCRC?"
by Dr.Luangyot Thongthieang
Meeting record.
"TAIHO weekly Live season2"
EP.8 26th May, 2022
"The Efficacy and Safety in Later Line Treatment of mCRC from US Real World Data"
by Dr.Busyamas Chewaskulyong
Meeting record.
"TAIHO weekly Live season2"
EP.7 19th May, 2022
"Case Sharing : The Extremely Doublet Regimen in 3rd line Treatment mCRC"
by Dr.Passakorn Wanchaijiraboon
Meeting record.
"TAIHO weekly Live season2"
EP.6 12nd May, 2022
"Case Sharing : The Improvement of Survival with Prolonged PS in 3rd line Treatment mCRC"
by Dr.Sureerat Jaruhathai
Meeting record.
"TAIHO weekly Live season2"
EP.5 5th May, 2022
"The Efficacy and Safety in Later Line Treatment of mCRC from Japanese Real World Data"
by Dr.Nuttapong Topibulpon
Meeting record.
"TAIHO weekly Live season2"
EP.4 29th April 2022
" The Tolerability of Chemotherapy in Elderly Lung Cancer Patients"
by Dr.Piti Pornpraserthsuk
Meeting record.
"TAIHO weekly Live season2"
EP.3 22nd April 2022
" Case Sharing : Extended the survival in Advanced Biliary Tract Cancer"
by Dr.Asasiri Kankaew
Meeting record.
"TAIHO WEEKLY LIVE season2"
EP.2 8th April 2022
"Treatment Option and Maintenance of ECOG PS with Previous Heavily Treatment in Gastric Cancer”
by Dr.Nattaya Teeyapan
"TAIHO WEEKLY LIVE season2"
EP.1 1st April 2022
" Survival Benefits of Doublet Chemotherapy with Immunotherapy for First-Line Treatment of Gastric Cancer”
by Dr.Piyawan Thienchaiananda
Meeting record.
TAIHO Virtual meeting Friday 3rd December 2021 at 5.00 - 6.30 PM.
Extend the Continuum of Care and Improve Patient Outcomes in 3L and beyond of mCRC